| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,424,000 | 4,373,000 | 4,906,000 | 4,478,000 | | Cost of Revenue | 1,092,000 | 1,061,000 | 1,610,000 | 3,719,000 | | | Gross Profit | 2,332,000 | 3,312,000 | 3,296,000 | 759,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,293,000 | 1,838,000 | 1,740,000 | (304,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 370,000 | 358,000 | 349,000 | 349,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 669,000 | 1,116,000 | 1,207,000 | 714,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,000) |
-
| (6,000) | (5,000) | | Earnings Before Interest And Taxes | 666,000 | 1,116,000 | 1,201,000 | 709,000 | | Interest Expense | 198,000 | 137,000 | 122,000 | 140,000 | | Income Before Tax | 468,000 | 979,000 | 1,079,000 | 569,000 | | Income Tax Expense | 175,000 | 364,000 | 384,000 | 219,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 293,000 | 615,000 | 695,000 | 350,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 293,000 | 615,000 | 695,000 | 350,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $293,000 | $615,000 | $695,000 | $350,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
